ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,179Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 680

$1.07M Total Retail Price of All Prescriptions

Rank: 67 out of 680

888 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 888 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 888 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,537 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 967 648 S3 1 4
ALPRAZOLAM 495 431 2 72
SIMVASTATIN 472 415 3 3
OMEPRAZOLE 431 374 4 7
PRAVASTATIN SODIUM 419 362 5 10
ZOLPIDEM TARTRATE 414 314 6 17
LISINOPRIL 405 314 7 5
AMLODIPINE BESYLATE 387 335 8 1
METFORMIN HCL 381 309 9 8
LEVOTHYROXINE SODIUM 349 277 10 2
FUROSEMIDE 327 236 11 6
HYDROCHLOROTHIAZIDE 268 241 12 9
LOSARTAN POTASSIUM 237 159 13 21
WARFARIN SODIUM 203 179 14 20
FENOFIBRATE 196 172 15 66
NEXIUM 175 99 16 16
METOPROLOL TARTRATE 172 148 17 12
DIAZEPAM 172 83 10 17 188
TEMAZEPAM 170 150 19 155
CARVEDILOL 156 141 20 23
LORAZEPAM 156 99 20 125
NABUMETONE 154 147 22 174
ATENOLOL 153 129 23 19
ALENDRONATE SODIUM 150 149 24 32
PROAIR HFA 147 126 25 67
LOVASTATIN 142 103 26 44
ATORVASTATIN CALCIUM 141 121 27 11
DICLOFENAC SODIUM 140 118 28 162
CLOPIDOGREL 131 119 29 26
METOPROLOL SUCCINATE 126 104 30 13
CITALOPRAM HBR 121 97 31 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 95 32 37
IRBESARTAN 120 104 32 247
LOSARTAN-HYDROCHLOROTHIAZIDE 118 104 34 51
PANTOPRAZOLE SODIUM 113 103 35 30
TAMSULOSIN HCL 112 107 36 34
PLAVIX 109 103 37 39
AMLODIPINE BESYLATE-BENAZEPRIL 101 82 38 43
LANTUS SOLOSTAR 98 56 39 84
AZITHROMYCIN 95 70 40 42
LANTUS 94 83 41 49
BENAZEPRIL HCL 94 75 41 40
CRESTOR 91 77 43 25
INSULIN SYRINGE 87 68 44 86
FLUTICASONE PROPIONATE 87 72 44 41
ADVAIR DISKUS 81 54 46 53
CEFDINIR 80 50 47 212
ALLOPURINOL 79 63 48 33
INDOMETHACIN 78 68 R 49 325
SPIRIVA 78 62 49 70
AMITRIPTYLINE HCL 74 40 R 51 47
SERTRALINE HCL 71 48 52 28
VENLAFAXINE HCL ER 70 46 53 101
PRAMIPEXOLE DIHYDROCHLORIDE 68 48 54 204
HYDROCODONE BIT-IBUPROFEN 68 37 S3 54 327
GLIPIZIDE ER 66 49 56 108
FLUOXETINE HCL 66 53 56 74
ACTOS 65 43 58 114
DONEPEZIL HCL 64 57 59 27
ESCITALOPRAM OXALATE 62 52 60 45
POTASSIUM CHLORIDE 61 55 61 14
TRIAMTERENE-HCTZ 61 49 61 52
CIPROFLOXACIN HCL 60 46 63 57
ZOLPIDEM TARTRATE ER 58 37 64 433
GEMFIBROZIL 58 43 64 106
MELOXICAM 57 54 66 24
PAROXETINE HCL 57 17 66 76
CELEBREX 56 41 68 90
ISOSORBIDE MONONITRATE ER 55 50 69 59
LANSOPRAZOLE 55 40 69 184
BUTALBITAL-ACETAMINOPHEN-CAFFE 54 29 R 71 346
RANITIDINE HCL 52 34 72 56
CYMBALTA 52 32 72 46
DOXAZOSIN MESYLATE 51 27 74 73
ZOSTAVAX 51 43 74 230
AVAPRO 51 47 74 329
VIAGRA 51 40 74 214
ENALAPRIL MALEATE 50 34 78 65
NAMENDA 50 50 78 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.